Topical Diclofenac (Voltaren) for Lateral Epicondylitis
Topical diclofenac is an appropriate and effective treatment option for lateral epicondylitis, particularly for short-term pain relief, though it should be considered as part of a broader conservative management strategy that prioritizes exercise therapy as the primary intervention.
Evidence-Based Recommendation
The FDA-approved Voltaren gel formulation provides systemic exposure to only 6% of oral diclofenac levels, with plasma concentrations reaching only 1-3 ng/mL at steady state—approximately 1% bioavailability compared to oral administration 1. This minimal systemic absorption translates to a favorable safety profile while maintaining local therapeutic efficacy.
Clinical Efficacy Data
Pain relief occurs rapidly with topical diclofenac:
- Significant pain reduction begins at 3 hours post-application, notably before diclofenac appears in plasma (mean 4.5 hours, range 2-8 hours) 2
- This temporal dissociation between pain relief and systemic absorption confirms local tissue accumulation as the primary mechanism of action
- The apparent half-life of 9-12 hours after patch application (versus 1-2 hours for oral diclofenac) further supports the presence of a tissue reservoir 2
Specific evidence for epicondylitis:
- In a randomized, double-blind crossover trial of 14 patients with chronic lateral epicondylitis, 2% diclofenac in pluronic lecithin liposomal organo-gel significantly reduced pain (VAS 2.1 vs. 3.6 for placebo) and increased wrist extension strength (8.4 kg vs. 5.9 kg pre-treatment) 3
- A multicenter trial of 158 patients with shoulder periarthritis and lateral epicondylitis demonstrated superior pain reduction with diclofenac lecithin gel versus placebo at day 3 (-20.1 mm vs. -9.9 mm, p<0.001) and day 6 (-33.2 mm vs. -21.2 mm, p<0.001) 4
Positioning Within Treatment Algorithm
The 2024 Japanese Orthopaedic Association guidelines establish the evidence hierarchy 5:
- Exercise therapy has the strongest evidence and should be the foundation of treatment
- Topical NSAIDs like diclofenac serve as appropriate adjunctive therapy for symptom control
- Consider injection therapy (corticosteroids or ketorolac) if conservative measures fail
Conservative management approach:
- Apply Voltaren gel (1%) three times daily to the affected lateral elbow area for 1-2 weeks initially 4, 3
- Combine with structured exercise therapy (eccentric strengthening, stretching)
- Activity modification and relative rest from aggravating movements
- Reassess at 2-4 weeks; if inadequate response, consider injection therapy
Safety Considerations
Topical diclofenac has minimal systemic effects:
- No drug-related gastrointestinal bleeding, ulcers, or Stevens-Johnson syndrome reported in 15 years of use 2
- Local adverse events are uncommon (one case of local rash in the 14-patient trial) 3
- Avoid concomitant use with oral NSAIDs, as combined use may increase systemic NSAID exposure and adverse effects 1
Critical contraindications and interactions from FDA labeling 1:
- Do not combine with other topical products (sunscreens, lotions, cosmetics) on the same site—may alter absorption and tolerability
- Use caution with anticoagulants (synergistic GI bleeding risk)
- May diminish effects of ACE inhibitors and diuretics
- Increases lithium levels and methotrexate toxicity
- Enhances cyclosporine nephrotoxicity
Clinical Pitfalls to Avoid
- Do not use topical diclofenac as monotherapy—exercise therapy remains the cornerstone with strongest evidence 5
- Avoid prolonged use without reassessment—if no improvement by 2-4 weeks, escalate to injection therapy rather than continuing ineffective topical treatment
- Do not apply to broken skin or with occlusive dressings—not studied and may alter absorption 1
- Screen for oral NSAID use—combined use increases systemic exposure and risk 1
Duration-Based Treatment Considerations
Recent evidence suggests treatment response varies by symptom chronicity 6:
- Acute cases (<12 months): Topical NSAIDs may provide adequate symptom control alongside exercise therapy
- Chronic cases (≥12 months): Consider earlier escalation to injection therapy if topical treatment fails within 2-4 weeks, as chronic epicondylitis may respond better to corticosteroid injections in the short term
The practical approach: Start with topical diclofenac gel three times daily combined with exercise therapy for 2-4 weeks. If pain persists or functional limitations continue, proceed to injection therapy (corticosteroid for short-term relief or ketorolac as steroid-sparing alternative) rather than prolonging ineffective topical treatment.